中国儿童及青少年分化型甲状腺癌诊疗指南(2026年版)计划书OA

To further standardize clinical decision-making and unify the diagnostic and therapeutic criteria for differentiated thyroid carcinoma in children and adolescents in China,it is urgent to develop a national clinical practice guideline based on high-quality evidence to suit the characteristics of pediatric and adolescent patients with differentiated thyroid carcinoma.In accordance with the World Health Organization(WHO)methodology for standard guideline development,this protocol elaborates on the registration information,development background and significance,target population,collection of key clinical questions,selection and definition of outcome indicators,strategies for evidence retrieval and quality assessment,and the formulation methodology of recommendation statements for the Chinese guideline for the diagnosis and treatment of differentiated thyroid carcinoma in children and adolescents(2026 edition).This protocol also describes the plans for formal publication,academic dissemination and nationwide clinical implementation of the guideline.This protocol aims to ensure a scientific,standardized and complete guideline development process and to provide reliable evidence-based references and practical guidance for standardized and homogeneous whole-course diagnosis and treatment of differentiated thyroid carcinoma in children and adolescents in China.